Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

BN

Key Insights on Series Investment

A strong performer from today's afternoon trading session is Series, whose shares rose 1.1% to $46.69 per share. For those of you thinking about investing in the stock, here is a brief value analysis of the stock using the company's basic fundamental ratios.

Series's Valuation Is in Line With Its Sector Averages:

Brookfield Corporation is an alternative asset manager and REIT/Real Estate Investment Manager firm focuses on real estate, renewable power, infrastructure and venture capital and private equity assets. The company belongs to the Real Estate sector, which has an average price to earnings (P/E) ratio of 27.31 and an average price to book (P/B) ratio of 1.94. In contrast, Series has a trailing 12 month P/E ratio of 155.6 and a P/B ratio of 2.46.

Series has moved 26.7% over the last year compared to 16.6% for the S&P 500 — a difference of 10.1%. Series has a 52 week high of $49.47 and a 52 week low of $29.07.

A Declining EPS Growth Trend and Negative Cash Flows:

2019 2020 2021 2022 2023 2024
Revenue (M) $67,826 $62,752 $75,731 $92,769 $95,924 $86,006
Net Margins 8% 1% 16% 6% 5% 2%
Net Income (M) $5,354 $707 $12,388 $5,195 $5,105 $1,853
Earnings Per Share $1.73 -$0.12 $2.39 $1.19 $0.61 $0.31
EPS Growth n/a -106.94% 2091.67% -50.21% -48.74% -49.18%
Free Cash Flow (M) -$56,330 -$18,531 -$52,957 -$57,291 $6,467 $7,569
Total Debt (M) $7,083 $9,077 $9,963 $11,390 $11,552 $12,368
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS